Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference
Larissa Fabritz(University of Birmingham), Burcu Vardar(Bayer (Belgium)), Helmut Pürerfellner(Krankenhaus der Elisabethinen), Isabelle C. Van Gelder(University Medical Center Groningen), Lars Eckardt(University of Münster), Stefan H. Hohnloser(Goethe University Frankfurt), Jeff S. Healey(Cliniques du Sud Luxembourg), A. John Camm(St George's, University of London), Doreen Haase(Atrial Fibrillation NETwork), Christina Dimopoulou(GSI Helmholtz Centre for Heavy Ion Research), Ingo Kutschka(Atrial Fibrillation NETwork), Eduard Guasch(Centro de Investigación en Red en Enfermedades Cardiovasculares), Jan Steffel(Zurich Heart House), Christophe Leclercq(Hôpital Pontchaillou), Dobromir Dobrev(West German Heart and Vascular Center Essen), Moritz F. Sinner(LMU Klinikum), Christian Meyer(Düsseldorf University Hospital), Andreas Goette(Otto-von-Guericke University Magdeburg), Dierk Thomas(Heidelberg University), Gregory Y.H. Lip(University of Liverpool), Jordi Heijman(Maastricht University Medical Centre), Aaron Isaacs(Erasmus MC), Mirko De Melis(Medtronic (Netherlands)), Lluı́s Mont, Christina Easter(University of Birmingham), Monika Stoll(Kiel University), Michiel Rienstra, Tatjana Potpara, Anthony K.C. Chan(McMaster Children's Hospital), Alice Sitch(University of Birmingham), Stephan Willems(Asklepios Klinik St. Georg), Elena Andreassi Marinelli(Daiichi Sankyo (Germany)), Thorsten Lewalter(München Klinik), Jonas Oldgren, Thomas Huebner(Johns Hopkins University), José Luís Merino(Hospital Universitario La Paz), Ursula Ravens(University Medical Center Hamburg-Eppendorf), Michael Näbauer(Ludwig-Maximilians-Universität München), Winnie Chua(University of Birmingham), Renate B. Schnabel(University Medical Center Hamburg-Eppendorf), Harry J.G.M. Crijns, Emma Svennberg(Karolinska University Hospital), Bushra Saeed Ilyas(Pfizer (United States)), Kenneth M. Steín(Boston Scientific (United States)), Rüdiger Smolnik(Philipps University of Marburg), G Breithardt(University Hospital Münster), Karl Georg Häusler(Universität Hamburg), Dipak Kotecha(University Hospitals Birmingham NHS Foundation Trust), Irina Savelieva(St George's, University of London), Stéphane Hatem
Cited by 69
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k